Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial

Lorenzo Falchi, Anna Sureda Balari, Sirpa Leppä, Joost S.P. Vermaat, Marcel Nijland, Jacob Haaber Christensen, Sven De Vos, Harald Holte, Reid W. Merryman, Pieternella J. Lugtenburg, Pau Abrisqueta Costa, Kim Linton, Gauri Sunkersett, Christopher Morehouse, Andrew J. Steele, Jennifer Marek, Wang Liwei, Daniela Hoehn, Martin Hutchings, David Belada

Research output: Contribution to journalMeeting Abstractpeer-review

4 Downloads (Pure)
Original languageEnglish
Pages (from-to)342-344
Number of pages3
JournalBlood
Publication statusPublished - 2024
Event66th ASH Annual Meeting & Exposition - San Diego, United States
Duration: 7 Dec 202410 Dec 2024
https://www.hematology.org/meetings/annual-meeting/schedule-and-program

Cite this